RDEA3170 Monotherapy in Subjects With Gout

NCT01927198 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Placebo
DRUG: RDEA3170 5 mg
DRUG: RDEA3170 10 mg
DRUG: RDEA3170 12.5 mg

Sponsor

Ardea Biosciences, Inc.